A review of recent research and development on GLP-1 receptor agonists-sustained-release microspheres
It focused on individual-level randomized clinical trial (RCT) data of GLP1-RA from the HARMONY program [Liraglutide (389 individuals) and Albiglutide (1,682 individuals)], the PRIBA study [Liraglutide (397 individuals), exenatide (223 individuals), and Tayside & Fife (415 individuals)
Unlike natural amylin, which has a very short half-life, cagrilintide's molecular structure allows for once-weekly administration, making it considerably more practical for research applications
Important: No clinical trial has directly studied split-dose or sub-2mg retatrutide
With the help of CU Anschutz Innovations, the research team launched a startup to further advance these new therapies and will soon find if their fundamental discovery works
Shipping & Fulfillment Orders are processed through Regentides fulfillment workflow and shipped securely from our USA-based facility